skip to content

Partnering with Diagnostics

Passionate about science - regardless of where it comes from

Roche was one of the first companies to recognise the importance of external innovation. Diagnostics has been partnering for more than 20 years with companies and research institutes worldwide. Since then, we have maintained a model that values external innovation as highly as our own internal development and established collaborations as the cornerstone of our R&D strategy.

Who we are

Roche Diagnostics is the market leader in the in vitro diagnostics business and provides the largest number of test results, empowering physicians and patients to make informed health decisions.

Roche is market leader in in-vitro diagnostics


tests conducted with Roche instruments in 2021

acquisitions since 2014


active in-licensing agreements


active out-licensing agreements


R&D investment in 2024 across the Roche Diagnostics Division


Where we are

Diagnostics Partnering offers speed, flexibility and accessibility to our partners. We have offices in Santa Clara, Tucson, Pleasanton, Boston, Basel (HQ), Rotkreuz, Penzberg and Shanghai.

Decorative illustration

Our partnering process

The Roche partnering process can be encapsulated in four steps.

Defining our search

Identifying partners

Personalising deals

Building relationships

At each step we can modify and tailor the relationship to the specific needs of each potential partner and depending on what is best for the asset. We find that this flexible approach is welcomed by our partners, and in our experience delivers the best results.